{"id":370,"date":"2026-09-09T05:40:29","date_gmt":"2026-09-09T05:40:29","guid":{"rendered":"https:\/\/www.thinkastute.com\/blog\/?p=370"},"modified":"2026-09-09T05:40:32","modified_gmt":"2026-09-09T05:40:32","slug":"best-fractional-cfo-advisory-for-biotech-startups","status":"publish","type":"post","link":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/","title":{"rendered":"Best Fractional CFO Advisory for Biotech Startups\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Biotech startups operate differently from most early-stage companies. They may spend years on research, regulatory approvals, and clinical development before generating meaningful revenue.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That makes cash planning, R&amp;D tracking, fundraising, and financial reporting especially important. The right fractional CFO can help founders manage these areas without hiring a full-time CFO too early.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why Biotech Startups Need Specialized CFO Expertise<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A biotech CFO needs to understand more than budgeting and bookkeeping.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Financial planning may need to account for clinical trial timelines, CRO payments, R&amp;D programs, grants, licensing agreements, regulatory milestones, and future fundraising rounds.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A delay in one development program can change the company\u2019s cash runway significantly. Founders therefore need financial forecasts that connect spending directly to scientific and business milestones.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Best Fractional CFO Services for Biotech Startups<\/strong>&nbsp;<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Early-Stage CFO Support<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">For preclinical and early-stage biotech companies, the priority is usually cash visibility.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fractional CFO support should help founders answer practical questions: How much runway do we have? What happens if development takes six months longer? How much capital will we need before the next milestone?&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Key support includes:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cash runway forecasting\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Budgeting\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Scenario planning\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fundraising models\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Board and investor reporting\u00a0<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The goal is not simply to produce a budget. It is to connect financial decisions with the company&#8217;s scientific and business milestones.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CFO Support for Clinical-Stage Companies&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Clinical-stage companies need more detailed forecasting around trial activity.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patient enrollment, CRO payments, site costs, regulatory activities, and changing timelines can materially affect cash requirements.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A fractional CFO should be able to model different clinical scenarios, track actual spending against forecasts, and show management how a delay or change in trial activity could affect runway.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This helps management understand how clinical changes could affect runway and future capital needs.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>CFO + Accounting Support<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Good strategy depends on reliable numbers.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Growing biotech companies may need more than high-level CFO advice. Combining CFO support with accounting can help improve:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Monthly close\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>R&amp;D cost tracking\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Financial reporting\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>AP and cash management\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Audit readiness\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Internal financial controls\u00a0<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Having finance and accounting working together also reduces the risk of management making decisions from incomplete or outdated financial information.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>CFO + R&amp;D and Technical Accounting Support<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Biotech companies can also face complex accounting around R&amp;D expenditures, grants, licensing agreements, collaboration arrangements, equity compensation, and revenue recognition.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Providers with technical accounting and R&amp;D expertise can help reduce the need to coordinate several separate advisors.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/thinkastute.com\/\">Astute<\/a><\/strong>, combines outsourced CFO advisory with technical accounting and R&amp;D tax credit capabilities, allowing biotech companies to address strategic and accounting requirements through a connected finance team.\u00a0<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Fundraising and Investor-Ready CFO Support<\/strong>\u00a0<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Fundraising is another point where specialized CFO support is important.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Investors will want more than historical financial statements. Founders should be prepared to explain their burn rate, runway, use of proceeds, development assumptions, and future capital requirements.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A strong fractional CFO can turn these assumptions into a financial model that management can defend in investor discussions.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How to Choose the Right Biotech Fractional CFO&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Founders should look beyond general startup CFO experience.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A strong <a href=\"https:\/\/www.thinkastute.com\/business-consulting\/outsourced-cfo-fractional-controller-services\/\">biotech fractional CFO <\/a>should understand:\u00a0<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Biotech and life sciences business models\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>R&amp;D and clinical-stage spending\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cash runway and scenario modeling\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fundraising and investor expectations\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Technical accounting\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Audit and financial reporting requirements\u00a0<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The provider should also be able to scale its support as the company moves from research to clinical development and eventually commercialization.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>When Should a Biotech Startup Hire a Fractional CFO?<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CFO-level support often becomes valuable when a company is:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Preparing for a major funding round like Seed\/Series A or another institutional raise\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Entering clinical development\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Managing multiple R&amp;D programs\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Receiving grants or non-dilutive funding\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Preparing for an audit\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Negotiating licensing or collaboration agreements\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Facing increasingly complex board reporting\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Finance is becoming too complex for the founder\/bookkeeper\/controller alone\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>You are entering into licensing or collaboration agreements.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Your runway depends on reaching a specific clinical milestone.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Your lead program is moving from discovery into IND-enabling studies.\u00a0<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What an Astute Supports Biotech Companies<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Astute combines fractional CFO advisory with accounting, technical accounting, and R&amp;D tax credit support.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For biotech companies, this can create a more connected finance function\u2014from runway forecasting and investor reporting to R&amp;D cost tracking, compliance, and financial reporting.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The objective is not simply better reporting. It is giving founders reliable financial visibility before they make important funding, development, or growth decisions.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Final Takeaway<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The best fractional CFO service for a biotech startup depends on its stage, financial complexity, and next major milestone.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Founders should look for a partner that understands both startup finance and the unique financial realities of biotech.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>FAQs<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>When should a biotech startup hire one?<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Usually when fundraising, clinical development, R&amp;D spending, or reporting becomes too complex to manage internally.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Does a biotech startup need a full-time CFO?<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Not always. A fractional CFO can provide senior financial expertise before a full-time hire makes financial sense.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Building the financial infrastructure for your next biotech milestone?<\/strong>\u00a0<br>Talk with Astute about fractional CFO, accounting and R&amp;D support.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does a fractional CFO do for a biotech startup?<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">They support forecasting, runway management, fundraising, financial reporting, and strategic finance decisions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech startups operate differently from most early-stage companies. They may spend years on research, regulatory approvals, and clinical development before generating meaningful revenue.&nbsp; That makes cash planning, R&amp;D tracking, fundraising,&hellip;<\/p>\n","protected":false},"author":2,"featured_media":372,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[127,15],"tags":[128,129,131,130],"class_list":["post-370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotech","category-startups","tag-best-fractional-cfo-advisory-for-biotech-startups","tag-best-fractional-cfo-services-for-biotech-startups","tag-what-an-astute-supports-biotech-companies","tag-when-should-a-biotech-startup-hire-a-fractional-cfo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Fractional CFO for Biotech Startups | Astute<\/title>\n<meta name=\"description\" content=\"Learn how a fractional CFO for biotech startups supports runway planning, R&amp;D tracking and investor reporting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fractional CFO for Biotech Startups | Astute\" \/>\n<meta property=\"og:description\" content=\"Learn how a fractional CFO for biotech startups supports runway planning, R&amp;D tracking and investor reporting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/\" \/>\n<meta property=\"og:site_name\" content=\"ThinkAstute Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-09T05:40:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-09T05:40:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"971\" \/>\n\t<meta property=\"og:image:height\" content=\"729\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sandhya Mukkamala\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandhya Mukkamala\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/\",\"url\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/\",\"name\":\"Fractional CFO for Biotech Startups | Astute\",\"isPartOf\":{\"@id\":\"https:\/\/www.thinkastute.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg\",\"datePublished\":\"2026-09-09T05:40:29+00:00\",\"dateModified\":\"2026-09-09T05:40:32+00:00\",\"author\":{\"@id\":\"https:\/\/www.thinkastute.com\/blog\/#\/schema\/person\/6e74ae6bd115c7e6cfba4e1980b9b3ec\"},\"description\":\"Learn how a fractional CFO for biotech startups supports runway planning, R&D tracking and investor reporting.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#primaryimage\",\"url\":\"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg\",\"contentUrl\":\"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg\",\"width\":971,\"height\":729,\"caption\":\"Best Fractional CFO Advisory for Biotech Startups\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thinkastute.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Best Fractional CFO Advisory for Biotech Startups\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thinkastute.com\/blog\/#website\",\"url\":\"https:\/\/www.thinkastute.com\/blog\/\",\"name\":\"ThinkAstute Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thinkastute.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thinkastute.com\/blog\/#\/schema\/person\/6e74ae6bd115c7e6cfba4e1980b9b3ec\",\"name\":\"Sandhya Mukkamala\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thinkastute.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2023\/11\/cropped-sandhya-96x96.jpg\",\"contentUrl\":\"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2023\/11\/cropped-sandhya-96x96.jpg\",\"caption\":\"Sandhya Mukkamala\"},\"description\":\"Sandhya Mukkamala, CPA, Partner and Co-Founder at Astute, advises clients on R &amp;D Tax incentives, strategizing Tax planning, Technical accounting, Forensic Audits, and other corporate compliance related matters. She has more than 15 years of experience in audit and review engagements, complex M&amp;A due diligence audits, Accounting for Income Tax Provisions (ASC-740) and Corporate Tax planning for private and public sectors. Contact me\",\"url\":\"https:\/\/www.thinkastute.com\/blog\/author\/sandhya-mukkamala\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fractional CFO for Biotech Startups | Astute","description":"Learn how a fractional CFO for biotech startups supports runway planning, R&D tracking and investor reporting.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/","og_locale":"en_US","og_type":"article","og_title":"Fractional CFO for Biotech Startups | Astute","og_description":"Learn how a fractional CFO for biotech startups supports runway planning, R&D tracking and investor reporting.","og_url":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/","og_site_name":"ThinkAstute Blog","article_published_time":"2026-09-09T05:40:29+00:00","article_modified_time":"2026-09-09T05:40:32+00:00","og_image":[{"width":971,"height":729,"url":"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg","type":"image\/jpeg"}],"author":"Sandhya Mukkamala","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sandhya Mukkamala","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/","url":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/","name":"Fractional CFO for Biotech Startups | Astute","isPartOf":{"@id":"https:\/\/www.thinkastute.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#primaryimage"},"image":{"@id":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg","datePublished":"2026-09-09T05:40:29+00:00","dateModified":"2026-09-09T05:40:32+00:00","author":{"@id":"https:\/\/www.thinkastute.com\/blog\/#\/schema\/person\/6e74ae6bd115c7e6cfba4e1980b9b3ec"},"description":"Learn how a fractional CFO for biotech startups supports runway planning, R&D tracking and investor reporting.","breadcrumb":{"@id":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#primaryimage","url":"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg","contentUrl":"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2026\/09\/blog-banner-go156.jpg","width":971,"height":729,"caption":"Best Fractional CFO Advisory for Biotech Startups"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thinkastute.com\/blog\/best-fractional-cfo-advisory-for-biotech-startups\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thinkastute.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Best Fractional CFO Advisory for Biotech Startups\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.thinkastute.com\/blog\/#website","url":"https:\/\/www.thinkastute.com\/blog\/","name":"ThinkAstute Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thinkastute.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.thinkastute.com\/blog\/#\/schema\/person\/6e74ae6bd115c7e6cfba4e1980b9b3ec","name":"Sandhya Mukkamala","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thinkastute.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2023\/11\/cropped-sandhya-96x96.jpg","contentUrl":"https:\/\/www.thinkastute.com\/blog\/wp-content\/uploads\/2023\/11\/cropped-sandhya-96x96.jpg","caption":"Sandhya Mukkamala"},"description":"Sandhya Mukkamala, CPA, Partner and Co-Founder at Astute, advises clients on R &amp;D Tax incentives, strategizing Tax planning, Technical accounting, Forensic Audits, and other corporate compliance related matters. She has more than 15 years of experience in audit and review engagements, complex M&amp;A due diligence audits, Accounting for Income Tax Provisions (ASC-740) and Corporate Tax planning for private and public sectors. Contact me","url":"https:\/\/www.thinkastute.com\/blog\/author\/sandhya-mukkamala\/"}]}},"_links":{"self":[{"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/posts\/370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/comments?post=370"}],"version-history":[{"count":1,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/posts\/370\/revisions"}],"predecessor-version":[{"id":373,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/posts\/370\/revisions\/373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/media\/372"}],"wp:attachment":[{"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/media?parent=370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/categories?post=370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thinkastute.com\/blog\/wp-json\/wp\/v2\/tags?post=370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}